BiomX (NYSEAMERICAN:PHGE) Stock Price Down 3.8% – What’s Next?

BiomX Inc. (NYSEAMERICAN:PHGE)’s share price dropped 3.8% during trading on Thursday . The stock traded as low as $0.87 and last traded at $0.91. Approximately 62,883 shares changed hands during trading, an increase of 14% from the average daily volume of 55,024 shares. The stock had previously closed at $0.95.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and set a $2.00 price objective on shares of BiomX in a research report on Wednesday, January 8th.

BiomX Stock Up 4.9 %

The firm has a market capitalization of $17.43 million, a P/E ratio of -0.30 and a beta of 1.27.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).